Coronary heart disease and polymorphisms in genes affecting lipid metabolism and inflammation

被引：13

作者：

Cambien F. ^{[1
]}

机构：

[1] INSERM U525, Chu Pitié-Salpétrière Université Pierre et Marie Curie, 75013 Paris

来源：

Current Atherosclerosis Reports | 2005年 / 7卷 / 3期

关键词：

Cholesteryl Ester Transfer Protein; Familial Hypercholesterolemia; Arterioscler Thromb Vasc Biol; ABCA1 Gene; Cholesteryl Ester Transfer Protein Activity;

D O I：

10.1007/s11883-005-0005-5

中图分类号：

学科分类号：

摘要：

Several biologic systems contribute to the pathophysiology of atherosclerosis and its complications, and within each of these systems many genes have been explored to establish the possible implication of their variability in coronary heart disease (CHD) risk. This report is focused on recent results pertaining to lipid and inflammatory genes, their variability, and their relationship with intermediate phenotypes and CHD. For both systems, there is no evidence at the present time that testing genetic polymorphisms might be of any benefit to the patient, for the diagnosis or prognosis of CHD, or for tailoring drug prescription. Understanding the genetics of complex traits like CHD will require a system approach that allows a modeling of the interaction among genes as well as between genetic and nongenetic sources of variation. Copyright © 2005 by Current Science Inc.

引用

页码：188 / 195

页数：7

共 78 条

[11]

Thompson J., Lloyd D., Lira M., Milos P., Cholesteryl ester transfer protein promoter single-nucleotide polymorphisms in Sp1-binding sites affect transcription and are associated with high-density lipoprotein cholesterol, Clin. Genet., 66, pp. 223-228, (2004)

[12]

Ordovas J., Cupples L., Corella D., Et al., Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: The Framingham study, Arterioscler. Thromb. Vasc. Biol., 20, pp. 1323-1329, (2000)

[13]

Freeman D.J., Samani N.J., Wilson V., Et al., A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study, Eur. Heart J., 24, pp. 1833-1842, (2003)

[14]

Blankenberg S., Rupprecht H.J., Bickel C., Et al., Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease, J. Am. Coll. Cardiol., 41, pp. 1983-1989, (2003)

[15]

Kuivenhoven J., Jukema J., Zwinderman A., Et al., The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis, N. Engl. J. Med., 338, pp. 86-93, (1998)

[16]

Grooth G.J., Zerba K.E., Huang S., Et al., The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: No interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: A prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy, J. Am. Coll. Cardiol., 43, pp. 854-857, (2004)

[17]

Clee S., Zwinderman A., Engert J., Et al., Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease, Circulation, 103, pp. 1198-1205, (2001)

[18]

Tregouet D., Ricard S., Nicaud V., Et al., In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction, Arterioscler. Thromb. Vasc. Biol., 24, pp. 775-781, (2004)

[19]

Yamakawa-Kobayashi K., Yanagi H., Yu Y., Et al., Associations between serum high-density lipoprotein cholesterol or apolipoprotein AI levels and common genetic variants of the ABCA1 gene in Japanese school-aged children, Clin. Exp. Metab., 53, pp. 182-186, (2004)

[20]

Frikke-Schmidt R., Nordestgaard B.G., Jensen G.B., Tybjaerg-Hansen A., Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population, J. Clin. Invest., 114, pp. 1343-1353, (2004)

← 1 2 3 4 5 6 7 8 →